SEC Tracker
Get the app

Possible new Adicet Bio shares

ACETDilution

Known so far: no new shares from the prospectus covers read · shelf room about $16.8M · not yet read: warrants, converts, options, ATM.

Shelf room

  • Room today about $16.8M
  • One third of float $16.8M ($50.5M float, Jun 30, 2025)
  • Sold off it, 12 months nothing
How this is worked out

Shelf room about $16.8M on the S-3 of Mar 12, 2026: the baby-shelf rule (public float under $75M) caps sales at one third of the $50.5M public float stated as of Jun 30, 2025, $16.8M, nothing sold off it in the last 12 months. Sources: S-3 Mar 12, 2026, effective Mar 23, 2026 · public float, as of Jun 30, 2025.

What could become new Adicet Bio (ACET) shares, from its 10-Q, 10-K, S-3 or 424B filings.

Read so far: the cover share count (9.4M shares, +80% from 5.2M on Aug 5, 2025, adjusted for the 1-for-16 reverse split by Mar 10, 2026). Not read yet: warrants, convertible notes, options and RSUs and an ATM program. Read them on EDGAR: the latest 10-Q · S-3 shelf filings.

Shares outstanding

9.4M

Nov 2024 to Aug 2026: from 5.2M to 9.4M. Adjusted for the 1-for-16 reverse split by Mar 10, 2026: each earlier count is divided by the ratio of every split after it.

From the share count on the cover of each 10-Q and 10-K, dated as each cover states.